Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

ARCA biopharma (ABIO) News Today

ARCA biopharma logo
FMR LLC Acquires New Stake in ARCA biopharma Inc
2025 ARCA Menards Series schedule released
ARCA biopharma Inc (HQ10.SG)
ARCA biopharma, Inc. stock logo
ARCA biopharma Stock Scheduled to Reverse Split on Tuesday, September 3rd (NASDAQ:ABIO)
Shares of ARCA biopharma, Inc. (NASDAQ:ABIO - Free Report) are set to reverse split before the market opens on Tuesday, September 3rd. The 1-12 reverse split was announced on Friday, August 23rd. The number of shares owned by shareholders will be adjusted after the closing bell on Friday, August 30th.
ARCA biopharma, Inc. stock logo
ARCA biopharma, Inc. Announces Dividend of $1.59 (NASDAQ:ABIO)
ARCA biopharma, Inc. (NASDAQ:ABIO) declared a dividend on Wednesday, August 21st. Stockholders of record on Monday, August 26th will be given a dividend of 1.59 per share by the biopharmaceutical company on Wednesday, August 28th. The ex-dividend date is Thursday, August 29th.
ARCA biopharma, Inc. stock logo
ARCA biopharma (NASDAQ:ABIO) Raised to "Sell" at StockNews.com
StockNews.com raised ARCA biopharma to a "sell" rating in a report on Tuesday.
ARCA biopharma, Inc. stock logo
ARCA biopharma, Inc. (NASDAQ:ABIO) Major Shareholder Henderson Group Plc Janus Purchases 5,818 Shares
ARCA biopharma, Inc. (NASDAQ:ABIO - Get Free Report) major shareholder Henderson Group Plc Janus acquired 5,818 shares of the company's stock in a transaction that occurred on Friday, August 16th. The shares were bought at an average cost of $2.93 per share, for a total transaction of $17,046.74. Following the transaction, the insider now owns 2,117,213 shares of the company's stock, valued at $6,203,434.09. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Major shareholders that own 10% or more of a company's stock are required to disclose their transactions with the SEC.
ARCA biopharma Inc (HQ10.MU)
ARCA biopharma, Inc. stock logo
ARCA biopharma (NASDAQ:ABIO) Stock Crosses Above 50 Day Moving Average of $3.40
ARCA biopharma (NASDAQ:ABIO) Share Price Crosses Above Fifty Day Moving Average of $3.40
ARCA biopharma Inc
Get ARCA biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABIO and its competitors with MarketBeat's FREE daily newsletter.

Trump’s Back, but DC’s Coming for Your Money! (Ad)

Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…

Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov

ABIO Media Mentions By Week

ABIO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ABIO
News Sentiment

0.13

0.55

Average
Medical
News Sentiment

ABIO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ABIO Articles
This Week

2

2

ABIO Articles
Average Week

Get ARCA biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABIO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:ABIO) was last updated on 11/13/2024 by MarketBeat.com Staff
From Our Partners